Alliance Pharma plc

AIM:APH 주식 보고서

시가총액: UK£243.5m

Alliance Pharma 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Nick Sedgwick

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기less than a year
CEO 소유권n/a
경영진 평균 재임 기간7.2yrs
이사회 평균 재임 기간less than a year

최근 관리 업데이트

Recent updates

Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Sep 10
Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Is Alliance Pharma (LON:APH) A Risky Investment?

Jun 21
Is Alliance Pharma (LON:APH) A Risky Investment?

Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Feb 23
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

Nov 21
Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

May 26
We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

Mar 24
Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

Sep 30
We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

May 28
An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Mar 30
Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Dec 24
Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

Nov 19
Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

CEO

Nick Sedgwick (52 yo)

less than a year

테뉴어

Mr. Nicholas John Sedgwick, also known as Nick, is Chief Executive Officer and Director of Alliance Pharma plc from May 13, 2024. Sedgwick brings thirty years of consumer health experience across European,...

리더십 팀

이름위치테뉴어보상소유권
Andrew Franklin
CFO & Executive Director9.2yrsUK£310.18k0.036%
£ 86.9k
Nicholas Sedgwick
CEO & Directorless than a year데이터 없음데이터 없음
Stephen Kidner
Chief Scientific Affairs Officerno data데이터 없음데이터 없음
Cora McCallum
Head of Investor Relations & Corporate Communicationsno data데이터 없음데이터 없음
Christodoulos Chrysanthou
Group General Counsel & Company Secretary7.2yrs데이터 없음데이터 없음
Alex Duggan
Chief Commercial & Corporate Development Officerno data데이터 없음데이터 없음
Julie Skinner
Chief People Officer1.8yrs데이터 없음데이터 없음
Chris Delafield
Global Marketing Head of Kelo-Cote7.8yrs데이터 없음데이터 없음
Rhodri Smith
Head of Sourcingno data데이터 없음데이터 없음

7.2yrs

평균 재임 기간

경험이 풍부한 관리: APH 의 관리팀은 노련하고 경험 (평균 재직 기간 7.2 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Andrew Franklin
CFO & Executive Director9.2yrsUK£310.18k0.036%
£ 86.9k
Nicholas Sedgwick
CEO & Directorless than a year데이터 없음데이터 없음
Martin Sutherland
Independent Non-Executive Director1.8yrsUK£48.22k데이터 없음
Richard Crispin Jones
Senior Independent Non-Executive Director5.8yrsUK£58.84k0.013%
£ 30.6k
Camillo Pane
Independent Non Executive Chairless than a year데이터 없음데이터 없음
Kristof Neirynck
Independent Non-Executive Director2.9yrsUK£52.80k데이터 없음
Richard McKenzie
Independent Non-Executive Directorless than a yearUK£7.27k데이터 없음
Eva-Lotta Sjostedt
Independent Non-Executive Directorless than a yearUK£7.27k데이터 없음
Martin Camilo
Member of Supervisory Boardless than a year데이터 없음데이터 없음

1.0yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 이사회: APH 의 이사회는 경험(평균 재직 기간 1 년)으로 간주되지 않으므로 새 이사회가 필요합니다.